Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Columvi“
Suchtreffer
Begriffe & Kennungen
Columvi · 4.8 · Among the 11 patients who experienced Grade ≥ 2 tumour flare, 2 patients (18.2%) received analgesics, 6 patien
Eintrag öffnenColumvi · 4.8 · Among the 22 patients who experienced Grade 2 CRS after Columvi, 16 (72.7%) received tocilizumab, 15 (68.2%)
Eintrag öffnenColumvi · 4.8 · Among the 25 patients who experienced Grade 2 CRS after Columvi, 22 (88.0%) received tocilizumab, 15 (60.0%)
Eintrag öffnenColumvi · 4.8 · Any grade CRS (by ASTCT criteria) occurred in 44.2% of patients who received Columvi with gemcitabine and oxal
Eintrag öffnenColumvi · 4.8 · Any grade CRS (by ASTCT criteria) occurred in 67.6% of patients who received Columvi monotherapy, with Grade 1
Eintrag öffnenColumvi · 4.8 · CMV events were reported in 11 patients (6.4%) who received Columvi with gemcitabine and oxaliplatin, with 1 p
Eintrag öffnenColumvi · 4.8 · COVID-191 Very common Common* Respiratory tract infections2 Very common Common* Pneumonia3 Very common Common*
Eintrag öffnenColumvi · 4.8 · CRS of any grade occurred in 34.9% of patients following the first 2.5 mg dose of Columvi at Cycle 1 Day 8 wit
Eintrag öffnenColumvi · 4.8 · CRS of any grade occurred in 54.5% of patients following the first 2.5 mg dose of Columvi at Cycle 1 Day 8 wit
Eintrag öffnenColumvi · 4.8 · Colitis events (excluding infectious aetiology) were reported in 4/172 patients (2.3%) who received Columvi wi
Eintrag öffnenColumvi · 4.8 · Columvi in combination with gemcitabine and oxaliplatin
Eintrag öffnenColumvi · 4.8 · Columvi in combination with gemcitabine and oxaliplatin The most common adverse reactions (≥ 20%) were thrombo
Eintrag öffnenColumvi · 4.8 · Columvi monotherapy The most common adverse reactions (≥ 20%) were cytokine release syndrome, neutropenia, ana
Eintrag öffnenColumvi · 4.8 · Constipation Very common Very rare** Diarrhoea Very common Very rare** Gastrointestinal Nausea Very common Ver
Eintrag öffnenColumvi · 4.8 · Cytokine release syndrome Columvi monotherapy
Eintrag öffnenColumvi · 4.8 · Description of selected adverse reactions
Eintrag öffnenColumvi · 4.8 · General disorders and administration Pyrexia Very common Uncommon site conditions Aspartate aminotransferase i
Eintrag öffnenColumvi · 4.8 · Grade 2 CRS occurred in 10.5% of patients following the first Columvi dose (2.5 mg) with median time to onse
Eintrag öffnenColumvi · 4.8 · Grade 2 CRS occurred in 12.4% of patients following the first Columvi dose (2.5 mg) with median time to onse
Eintrag öffnenColumvi · 4.8 · Hospitalisations due to patients experiencing CRS following Columvi administration occurred in 19.8% of patien
Eintrag öffnen